People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lumos Pharma, Inc. | — | Pharmaceuticals | Series B | $53.5M | $1.2B | 2014 |
George Gilbert Cloyd at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside George Gilbert Cloyd on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jon S. Saxe | 1 | 5 |
| Richard John Hawkins | 1 | 2 |
| Kevin M. Lalande | 1 | 2 |
| Kevin S. Lelande | 1 | 1 |
| Robert S. Heft | 1 | 1 |
| Cameron Gilbert Wheeler | 1 | 1 |
| Michele Gilbert Park | 1 | 1 |
| Edward Gilbert Mathers | 1 | 1 |
| Tracy Gilbert Saxton | 1 | 1 |
| Edward J. Mathers | 1 | 1 |
| Robert J. Heft | 1 | 1 |
| G. Gilbert Cloyd | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.